0001104659-22-084835.txt : 20220801 0001104659-22-084835.hdr.sgml : 20220801 20220801180054 ACCESSION NUMBER: 0001104659-22-084835 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220624 FILED AS OF DATE: 20220801 DATE AS OF CHANGE: 20220801 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DRISCOLL FREDERICK W CENTRAL INDEX KEY: 0001129890 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36598 FILM NUMBER: 221126142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cellectar Biosciences, Inc. CENTRAL INDEX KEY: 0001279704 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043321804 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CAMPUS DRIVE CITY: FLORHAM PARK STATE: NJ ZIP: 07932 BUSINESS PHONE: (608) 441-8120 MAIL ADDRESS: STREET 1: 100 CAMPUS DRIVE CITY: FLORHAM PARK STATE: NJ ZIP: 07932 FORMER COMPANY: FORMER CONFORMED NAME: NOVELOS THERAPEUTICS, INC. DATE OF NAME CHANGE: 20050617 FORMER COMPANY: FORMER CONFORMED NAME: COMMON HORIZONS INC DATE OF NAME CHANGE: 20040211 4 1 tm2222253-2_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-06-24 0 0001279704 Cellectar Biosciences, Inc. CLRB 0001129890 DRISCOLL FREDERICK W C/O CELLECTAR BIOSCIENCES, INC. 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 1 0 0 0 Stock option (right to buy) 4.10 2022-06-24 4 A 0 7800 0 A 2032-06-24 Common Stock 7800 7800 D Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022. This stock option shall vest in full on June 24, 2023, subject to the reporting person's continued service through the applicable vesting date. /s/ Christina Blakley, attorney-in-fact for Frederick Driscoll 2022-08-01